Owing to increasing occurrences of stress and depression, obesity, long working hours, and high incidences of diabetes, Japan’s market for sleep apnea diagnostic equipment is expected to reach $100 million in 2030, forecasts GlobalData, a leading data and analytics company.

GlobalData’s report, “Sleep Apnea Diagnostic Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033,” reveals that in terms of value, Japan is the largest market for sleep apnea equipment in the Asia-Pacific region, accounting for around 45% of the market in 2023.

Rachna Tripathi, Medical Devices Analyst at GlobalData, comments: “It is crucial to acknowledge the rising prevalence of sleep disorders and their potential impact on health, as they may have extensive implications on the overall well-being. As awareness of this issue continues to rise, there is a clear need for advanced diagnostic and treatment solutions to enhance the quality of life for individuals.”

Shionogi and Apnimed have recently collaborated to establish Shionogi-Apnimed Sleep Science with the primary goal of addressing the increasing impact of obstructive sleep apnea (OSA) on global public health. This collaboration signifies their shared commitment to expedite innovative OSA solutions. The equally owned venture leverages the combined resources of both companies to effectively tackle sleep disorders, marking a significant step forward in improving the quality of life of individuals worldwide.

Tripathi concludes: “A significant contribution to advances in this area is being made by increasing awareness of sleep apnea disorders, collaboration efforts of companies, and development of new technologies such as advanced wearables devices, personalized approach for treatment and integration of artificial intelligence.”